Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review

Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. NAFLD often occurs associated with endocrinopathies. Evidence suggests that endocrine dysfunction may play an important role in NAFLD development, progression, and severity. Our work aimed to explore and summariz...

Full description

Bibliographic Details
Main Authors:	Madalena Von-Hafe, Marta Borges-Canha, Catarina Vale, Ana Rita Leite, João Sérgio Neves, Davide Carvalho, Adelino Leite-Moreira
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Metabolites
Subjects:	NAFLD fatty liver lipidomics metabolic modeling endocrine disorders
Online Access:	https://www.mdpi.com/2218-1989/12/4/298

Similar Items

The lipidome in nonalcoholic fatty liver disease: actionable targets
by: Carlos J. Pirola, et al.
Published: (2021-01-01)

Nonalcoholic fatty liver disease stratification by liver lipidomics
by: Olga Vvedenskaya, et al.
Published: (2021-01-01)

Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
by: Jian Huang, et al.
Published: (2023-04-01)

Nobiletin Intake Attenuates Hepatic Lipid Profiling and Oxidative Stress in HFD-Induced Nonalcoholic-Fatty-Liver-Disease Mice
by: Zunli Ke, et al.
Published: (2023-03-01)

Pathophysiology of NASH in endocrine diseases
by: Karim Gariani, et al.
Published: (2021-03-01)

Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico
by: Yvonne N. Flores, et al.
Published: (2021-10-01)

The impact of thyroid hormone dysfunction on ischemic heart disease
by: Madalena von Hafe, et al.
Published: (2019-04-01)

Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers
by: Roshan Shafiha, et al.
Published: (2021-11-01)

Study on endocrine disruption effect of paclobutrazol and uniconazole on the thyroid of male and female rats based on lipidomics
by: Hui Liu, et al.
Published: (2022-04-01)

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
by: Monika Lewinska, PhD, et al.
Published: (2021-11-01)

Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in <i>Pparg</i>-Null Mice
by: Mariano Schiffrin, et al.
Published: (2021-09-01)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
by: Marta Borges-Canha, et al.
Published: (2020-10-01)

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
by: Shun Ishido, et al.
Published: (2023-06-01)

Interaction between sarcopenia and nonalcoholic fatty liver disease
by: Sae Kyung Joo, et al.
Published: (2023-02-01)

The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity
by: Borges-Canha M, et al.
Published: (2021-02-01)

Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial
by: Adrian Curran, et al.
Published: (2020-04-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Multi-Omics Approach Reveals Dysregulation of Protein Phosphorylation Correlated with Lipid Metabolism in Mouse Non-Alcoholic Fatty Liver
by: Sora Q. Kim, et al.
Published: (2022-03-01)

Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms
by: Ricardo Rodríguez-Calvo, et al.
Published: (2020-09-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01)

Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
by: Kevan Josloff, et al.
Published: (2022-11-01)

The Role of Phytosterols in Nonalcoholic Fatty Liver Disease
by: Otilia Frasinariu, et al.
Published: (2022-05-01)

Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Young-Su Yi
Published: (2024-03-01)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
by: Abhijit Pratap, et al.
Published: (2023-10-01)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
by: Ioanna Aggeletopoulou, et al.
Published: (2023-08-01)

Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes
by: Celia Sid-Otmane, et al.
Published: (2020-09-01)

RESISTIN GENE POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE RISK
by: Seidamir Pasha TABAEIAN, et al.
Published: (2022-11-01)

Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials
by: Joel Yeh Siang Chen, et al.
Published: (2022-12-01)

Dendritic Cells and T Cell Subsets in the Development of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Gulubova M., et al.
Published: (2021-10-01)

Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach
by: Natalia Nuño-Lámbarri, et al.
Published: (2016-03-01)

Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease
by: Fontini Tania Mitsinikos, et al.
Published: (2020-11-01)

Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
by: Birgit Knebel, et al.
Published: (2019-10-01)

Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease
by: Oliver K. Glass, et al.
Published: (2017-09-01)

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Genetic diagnosis of endocrine disorders /
by: Weiss, Roy E., et al.
Published: (c201)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Cyrielle Caussy, et al.
Published: (2020-10-01)

Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
by: João Sérgio Neves, et al.
Published: (2020-10-01)

Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)
by: Gabriele Mocciaro, et al.
Published: (2023-07-01)

Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
by: Alejandra Mijangos-Trejo, et al.
Published: (2023-10-01)